Hamlet Protein's new U.S. processing line will deliver higher volumes to customers worldwide.The investment is a response to rapidly developing sales of Hamlet Protein's nutritional soy protein ingredients, which are currently produced in Horsens, Denmark and Findlay, OH.
Farrowing need for speciality proteins
Over the past four years, the company has experienced a significant increase in demand for quality proteins that optimize nutritional uptake from feed and support healthy young animal growth.
Farmers in established and emerging markets increasingly choose Hamlet Protein as the protein source for improved production efficiency and profits.
Improved security of supply
“The rise in global food demand has created an urgent need for more efficient animal production. This, in turn, has pushed up demand for consistent supplies of quality protein, a trend that has drawn more attention to our strong value proposition. As a result, we are experiencing substantial sales growth across our product range,” says Chief Commercial Officer Søren Bank.
“Once our extra processing line is in place, we will not only offer higher volumes but also improved flexibility of supply for customers globally.”
New market penetration
Hamlet Protein commenced production at the U.S. plant in early 2012. Since then, sales growth has extended far beyond North America to South America and Asia.
“We target emerging markets where industrial meat production brings greater demands for quality and efficiency,” Bank states.
The new processing line will be installed in the existing factory building in Findlay.
“Our production plant in the USA has got off to a good start. We have been well received both locally in Findlay and on the U.S. market overall. This has contributed to our decision to install our new processing line at our Findlay plant.”
For more information:
Contact Chief Commercial Officer Søren Bank on + 45 75631020 or
V.P. NAFTA Sales and Marketing Mark Newcomb on +1 612 202 3592